Esin Tokmak Tokmak Özşahin1, Burcu Çam2, Fahri Dere3, Mehmet Kürkçü2, Cüneyt Evrüke4, Roger Soames5, Özkan Oğuz3. 1. Department of Anatomy, Başkent University Adana Hospital, Adana, Turkey. 2. Department of Maxillofacial and Oral Surgery, Çukurova University School of Dentistry, Adana, Turkey. 3. Department of Anatomy, Medical Faculty of Çukurova University, Adana, Turkey. 4. Department of Obstetrics and Gynecology, Medical Faculty of Çukurova University, Adana, Turkey. 5. Dundee University, Center for Anatomy, Dundee, England.
Abstract
OBJECTIVES: T Objectives: This study aims to investigate the effect of alendronate sodium on trabecular bone structure in an osteoporotic rat model. MATERIALS AND METHODS: Between May 2006 and July 2006, 60 female Wistar Albino rats aged three months were randomly allocated to three groups: sham operated receiving no treatment (Shm); ovariectomized-alendronate receiving 1 mg/kg/day alendronate sodium (Ovx-A), and ovariectomized-vehicle receiving 1 mL/kg/day physiological saline (Ovx-PS). Both Ovx groups received treatment through gastric gavage for 56 days. RESULTS: Densitometric measurements showed that bone mineral density decreased in the Ovx-PS and increased in Ovx-A groups (p<0.05). Biomechanical measurements showed a decrease in the breaking force in the Ovx-PS group and an increase in the Ovx-A group (p<0.05). Histomorphometric measurements showed that the Shm group had normal trabecular structure, while the Ovx-PS group had a less well- formed trabecular structure with a loss in the trabecular number and thickness and a corresponding increase in the trabecular spacing (p<0.05). In the Ovx-A group, there was an improvement in the trabecular structure with an increase in the trabecular number and thickness and a loss in the trabecular space (p<0.05). CONCLUSION: Our study results suggest that alendronate sodium is a valuable treatment agent for osteoporosis in postmenopausal women.
OBJECTIVES: T Objectives: This study aims to investigate the effect of alendronate sodium on trabecular bone structure in an osteoporotic rat model. MATERIALS AND METHODS: Between May 2006 and July 2006, 60 female Wistar Albino rats aged three months were randomly allocated to three groups: sham operated receiving no treatment (Shm); ovariectomized-alendronate receiving 1 mg/kg/day alendronate sodium (Ovx-A), and ovariectomized-vehicle receiving 1 mL/kg/day physiological saline (Ovx-PS). Both Ovx groups received treatment through gastric gavage for 56 days. RESULTS: Densitometric measurements showed that bone mineral density decreased in the Ovx-PS and increased in Ovx-A groups (p<0.05). Biomechanical measurements showed a decrease in the breaking force in the Ovx-PS group and an increase in the Ovx-A group (p<0.05). Histomorphometric measurements showed that the Shm group had normal trabecular structure, while the Ovx-PS group had a less well- formed trabecular structure with a loss in the trabecular number and thickness and a corresponding increase in the trabecular spacing (p<0.05). In the Ovx-A group, there was an improvement in the trabecular structure with an increase in the trabecular number and thickness and a loss in the trabecular space (p<0.05). CONCLUSION: Our study results suggest that alendronate sodium is a valuable treatment agent for osteoporosis in postmenopausal women.
Authors: H Rico; M Gómez; M Revilla; J González-Riola; C Seco; E R Hernández; L F Villa; J J Gervás Journal: Calcif Tissue Int Date: 1999-10 Impact factor: 4.333
Authors: Umani S Walallawita; Frances M Wolber; Ayelet Ziv-Gal; Marlena C Kruger; Julian A Heyes Journal: Int J Mol Sci Date: 2020-09-27 Impact factor: 5.923